Virology

HOT RECEPTION: From left, NIAID investigators Edward Berger, Paul Kennedy, Christopher Broder, and Yu Feng helped to break open the field of HIV coreceptor research with their discovery of fusin. Comments by Edward A. Berger, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases Within three years after the discovery of HIV as the causative agent of AIDS, scientists identified the CD4 molecule as the primary cellular receptor for HIV. They believed the virus ent

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Within three years after the discovery of HIV as the causative agent of AIDS, scientists identified the CD4 molecule as the primary cellular receptor for HIV. They believed the virus entered target cells by an initial binding event between the envelope glycoprotein (Env) molecules on the viral membrane and CD4 molecules on the target cell surface. Yet as early as 1986, it became clear that the Env-CD4 interaction was not sufficient to promote the fusion reaction that results in HIV infection. Research teams searched for a coreceptor for roughly a decade. In 1996, a research team from the National Institute of Allergy and Infectious Diseases (NIAID) led by Edward A. Berger, chief of the molecular structure section, Laboratory of Viral Diseases, discovered the HIV coreceptor they dubbed "fusin" (later CXCR4); this molecule allowed HIV infection in CD4-expressing nonhuman cells through fusion with Env-mediated cells, and it blocked infection and fusion ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs

Products

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform

nuclera logo

Nuclera eProtein Discovery System installed at leading Universities in Taiwan

Brandtech Logo

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control